Mechanotransduction in Aqueous Outflow Regulation and Open Angle Glaucoma
房水流出调节和开角型青光眼中的机械传导
基本信息
- 批准号:10091442
- 负责人:
- 金额:$ 37.22万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-04-01 至 2023-01-31
- 项目状态:已结题
- 来源:
- 关键词:AgreementAnteriorAqueous HumorAreaAtomic Force MicroscopyBindingBiochemicalBiological AssayBiomechanicsBiophysicsBlindnessCell Surface ReceptorsCellsCharacteristicsComplexCultured CellsDataDepositionDevelopmentDiseaseEnzymesEtiologyExtracellular MatrixExtracellular Matrix ProteinsEyeFoundationsGene ProteinsGlaucomaHomeostasisHumanHydrogelsITGA7 geneIn VitroIndividualIntegrin BindingIntegrinsLOX geneLamininLinkMeasurementMeasuresMechanicsMediatingModelingMolecularNatureOpen-Angle GlaucomaOrgan Culture TechniquesPathway interactionsPerfusionPhenotypePhysiologic Intraocular PressurePropertyProteinsProteomicsRegulationResistanceRisk FactorsRoleSignal TransductionSmall Interfering RNAStimulusStructure of sinus venosus of scleraSystemTherapeuticTimeTissuesTrabecular meshwork structureWestern Blottingaqueousbasebiophysical analysiscell behaviorcrosslinkenzyme activityinhibitor/antagonistinterdisciplinary approachmRNA Expressionmechanotransductionnovelnovel therapeutic interventionnovel therapeuticspressureprotein expressionresponse
项目摘要
PROJECT SUMMARY
Glaucoma is a leading cause of irreversible blindness worldwide. While the etiology of the disease is complex,
it is typically associated with elevated intraocular pressure (IOP) due to increased resistance to aqueous
humor outflow through the trabecular meshwork (TM). The human TM is approximately 20 fold stiffer in
glaucoma, suggesting a prominent role of TM mechanobiology. Although current outflow pathway models
estimate that the juxtacanalicular region of the TM contributes to 90-95% of the outflow resistance, it is widely
accepted that outflow itself is not uniform around the circumference of the TM, but is highly segmental with
regions of relatively high flow (HF), and low flow (LF). Although this has been recognized previously, nearly all
studies over the past few decades have essentially ignored this fact. Whether there are inherent differences in
TM cells of HF and LF regions and between non-glaucomatous and glaucomatous individuals remains unclear.
Preliminary data in support of this proposal shows that, with glaucoma tissues, there are more LF regions, they
are stiffer, and are associated with elevated matrix crosslinking enzyme activity. Conversely, HF regions are
softer, fewer, and have lower levels of crosslinking activity. Based on these and other observations, we have
hypothesized that there are innate differences in cells between the segmental flow regions, and these
directly regulate extracellular matrix (ECM) turnover, crosslinking, and outflow. The precise mechanism
that underlies the relative shift to increased LF regions is unclear. In order to mechanistically understand the
regulatory link between matrix biomechanics, composition, and segmental outflow, we will use two general
experimental approaches, (A) using perfused human anterior segment organ culture, we will compare
biomechanical and biochemical properties of HF and LF regions, measure crosslinking, and, isolate cells from
these; and (B) use cell derived matrices to determine cell-matrix interactions. Specifically, in Aim 1, we will
isolate TM cells from different flow regions of glaucomatous and non-glaucomatous TM, characterize cell
surface receptor distribution, and investigate their mechanotransduction response to biophysical stimuli. We
will also obtain and characterize cell derived ECM, and determine the effect that these ECM have on cellular
behavior. In Aim 2, we will ascertain and quantify the nature of ECM crosslinks, document differences in
crosslinking enzyme activity, and determine if inhibiting crosslinks changes the biomechanics and composition
of segmental regions in both normal and glaucomatous eyes. We will also determine if substratum
biomechanics modulates crosslinking in segmental flow cells. Finally, in Aim 3, we will use a targeted
approach to identify regulators of the homeostatic response and manipulate outflow regions. Particularly we
will target the specific role that ECM binding integrin α7β1 has in mediating outflow, ECM remodeling, and
shifts in segmental flow. Accomplishment of these aims will reveal a mechanism for TM cell-ECM interactions
and identify novel targets to reduce elevated IOP by increasing areas of active outflow, and treat glaucoma.
项目摘要
青光眼是全球不可逆失明的主要原因。虽然该疾病的病因很复杂,但
由于对水性的抗性增加,它通常与眼内压(IOP)相关
通过小梁网(TM)的幽默出口。人类TM大约20倍
青光眼,表明TM机械生物学的重要作用。尽管当前的出口通路模型
据估计,TM的近去核区域贡献了90-95%的出口电阻,它是广泛的
接受插座本身并不统一在TM的循环周围,而是高度分段的
流动相对较高(HF)和低流量(LF)的区域。尽管以前已经认可了这一点,但几乎全部
在过去的几十年中,研究基本上忽略了这一事实。是否存在继承差异
HF和LF区域的TM细胞以及非葡萄糖和青光眼个体之间的TM细胞尚不清楚。
支持该提案的初步数据表明,有了青光眼组织,有更多的LF区域,它们
被僵硬,与升高的基质交联酶活性有关。相反,HF地区是
较软,较少,交联活动的水平较低。基于这些和其他观察,我们有
假设,节段流区域之间的细胞存在差异,
直接调节细胞外基质(ECM)周转,交联和出口。精确机制
这是尚不清楚与LF区域增加的相对转变的基础。为了机械理解
基质生物力学,组成和节段插座之间的调节链接,我们将使用两个一般
实验方法,(a)使用灌注的人体前部器官培养,我们将比较
HF和LF区域的生物力学和生化特性,测量交联和分离细胞中的细胞
这些; (b)使用细胞衍生的矩阵确定细胞 - 矩阵相互作用。具体来说,在AIM 1中,我们将
来自青光眼和非葡萄糖良好TM的不同流动区域的分离TM细胞,表征细胞
表面受体分布,并研究其对生物物理刺激的机械传导反应。我们
还将获得并表征派生的ECM细胞,并确定这些ECM对细胞的影响
行为。在AIM 2中,我们将确定和量化ECM交联的性质,文件差异
交联酶活性,并确定抑制交联是否改变了生物力学和组成
在正常和青光眼中的节段区域。我们还将确定底层是否
生物力学调节节段流中的交联。最后,在AIM 3中,我们将使用目标
识别体内稳态响应和操纵输出流区域的调节器的方法。特别是我们
将针对ECM结合α7β1在介导出口,ECM重塑和
节段流的变化。这些目标的完成将揭示TM细胞ECM相互作用的机制
并确定新的靶标,通过增加活性出口区域并治疗青光眼来降低IOP的升高。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TED S ACOTT其他文献
TED S ACOTT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TED S ACOTT', 18)}}的其他基金
Molecular Mechanisms of Outflow Segmentation and Intraocular Pressure Homeostasis
流出分段和眼压稳态的分子机制
- 批准号:
8943562 - 财政年份:2015
- 资助金额:
$ 37.22万 - 项目类别:
Molecular Mechanisms of Outflow Segmentation and Intraocular Pressure Homeostasis
流出分段和眼压稳态的分子机制
- 批准号:
10229419 - 财政年份:2015
- 资助金额:
$ 37.22万 - 项目类别:
Molecular Mechanisms of Outflow Segmentation and Intraocular Pressure Homeostasis
流出分段和眼压稳态的分子机制
- 批准号:
10004627 - 财政年份:2015
- 资助金额:
$ 37.22万 - 项目类别:
Molecular Mechanisms of Outflow Segmentation and Intraocular Pressure Homeostasis
流出分段和眼压稳态的分子机制
- 批准号:
9115612 - 财政年份:2015
- 资助金额:
$ 37.22万 - 项目类别:
Molecular Mechanisms of Outflow Segmentation and Intraocular Pressure Homeostasis
流出分段和眼压稳态的分子机制
- 批准号:
10478291 - 财政年份:2015
- 资助金额:
$ 37.22万 - 项目类别:
相似国自然基金
肝胆肿瘤治疗性溶瘤腺病毒疫苗的研制及其临床前应用性探索
- 批准号:82303776
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
莫氏细胞早期异常活化介导的前下托-齿状回环路构建在癫痫发生中的作用研究
- 批准号:82371458
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
基于MST4-YAP-MYC信号通路的慢痞消调控氧化磷酸化水平治疗胃癌前病变的机制研究
- 批准号:82374292
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
CXCL12趋化CXCR4+/α-SMA+成骨前体细胞促进黄韧带骨化的机制研究
- 批准号:82302745
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
紫外光解中间体激活荧光构建亚硝胺及其前体物的新方法和机理研究
- 批准号:82373631
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
The role of distal aqueous humor outflow tissue in glucocorticoid-induced glaucoma
远端房水流出组织在糖皮质激素诱发青光眼中的作用
- 批准号:
10667863 - 财政年份:2023
- 资助金额:
$ 37.22万 - 项目类别:
Regulation of Intraocular Pressure via a Novel Adjustable Glaucoma Drainage Device
通过新型可调节青光眼引流装置调节眼压
- 批准号:
10735637 - 财政年份:2023
- 资助金额:
$ 37.22万 - 项目类别:
Racial disparities of open angle glaucoma: A study of mitochondria and oxidative stress in human trabecular meshwork
开角型青光眼的种族差异:人类小梁网线粒体和氧化应激的研究
- 批准号:
10735655 - 财政年份:2023
- 资助金额:
$ 37.22万 - 项目类别:
Anatomical and functional imaging of the conventional outflow pathway
传统流出通道的解剖和功能成像
- 批准号:
10752459 - 财政年份:2023
- 资助金额:
$ 37.22万 - 项目类别:
Establishment of experimental basis to improve the prognosis of corneal transplantation in treating bullous keratoplasty due to pathological aqueous humor.
为改善角膜移植治疗病理性房水所致大疱性角膜移植术的预后奠定实验基础。
- 批准号:
23H03063 - 财政年份:2023
- 资助金额:
$ 37.22万 - 项目类别:
Grant-in-Aid for Scientific Research (B)